GIANSANTE, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 7.134
EU - Europa 3.581
AS - Asia 2.693
SA - Sud America 254
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 71
OC - Oceania 15
Totale 13.909
Nazione #
US - Stati Uniti d'America 7.017
IT - Italia 1.406
SG - Singapore 1.003
CN - Cina 713
SE - Svezia 423
UA - Ucraina 376
DE - Germania 337
VN - Vietnam 225
HK - Hong Kong 221
BR - Brasile 203
FR - Francia 178
GB - Regno Unito 171
FI - Finlandia 169
RU - Federazione Russa 153
KR - Corea 150
TR - Turchia 119
BD - Bangladesh 88
PL - Polonia 83
CA - Canada 64
IE - Irlanda 64
BG - Bulgaria 62
IN - India 61
NL - Olanda 44
BE - Belgio 26
ES - Italia 20
MA - Marocco 20
MX - Messico 20
AR - Argentina 18
JP - Giappone 18
SN - Senegal 18
AU - Australia 14
CH - Svizzera 13
IQ - Iraq 12
PK - Pakistan 11
ID - Indonesia 10
KE - Kenya 10
TH - Thailandia 10
AT - Austria 9
EC - Ecuador 9
ZA - Sudafrica 9
CO - Colombia 8
CZ - Repubblica Ceca 7
VE - Venezuela 7
CR - Costa Rica 6
LT - Lituania 6
PH - Filippine 6
DK - Danimarca 5
EU - Europa 5
JO - Giordania 5
OM - Oman 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
EE - Estonia 4
EG - Egitto 4
HN - Honduras 4
PT - Portogallo 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
GR - Grecia 3
HR - Croazia 3
HU - Ungheria 3
RO - Romania 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
CL - Cile 2
DO - Repubblica Dominicana 2
IL - Israele 2
JM - Giamaica 2
KH - Cambogia 2
KW - Kuwait 2
LC - Santa Lucia 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
UG - Uganda 2
UZ - Uzbekistan 2
AL - Albania 1
AW - Aruba 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CM - Camerun 1
CU - Cuba 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 13.742
Città #
Woodbridge 867
Ann Arbor 699
Ashburn 635
Fairfield 585
Singapore 563
Houston 506
Chandler 428
Jacksonville 337
San Jose 310
Wilmington 274
Seattle 258
Hong Kong 215
Cambridge 208
Hefei 162
Beijing 161
Seoul 147
Milan 128
Princeton 123
Boardman 105
Izmir 101
Columbus 95
Dearborn 92
Council Bluffs 87
Chicago 85
Los Angeles 82
Rome 79
Trieste 74
Ho Chi Minh City 69
Dublin 65
Santa Clara 65
Lauterbourg 62
Sofia 62
Moscow 59
Zgierz 58
Hanoi 55
Buffalo 54
The Dalles 49
Helsinki 42
Munich 41
Dallas 34
Düsseldorf 31
Verona 31
New York 30
Turin 30
San Diego 29
Naples 27
Frankfurt am Main 26
Brussels 25
Bologna 24
Phoenix 24
Kunming 23
Nanjing 23
Bari 22
London 22
Ottawa 22
Warsaw 19
Dakar 18
Florence 18
São Paulo 18
Venezia 18
Casablanca 17
Grafing 17
Shanghai 17
Venice 17
Atlanta 16
Cagliari 16
Tokyo 16
Turku 16
Des Moines 15
Guangzhou 15
Montreal 15
Orem 15
Bremen 14
Haiphong 14
Mestre 14
Redondo Beach 14
Chennai 12
Jinan 12
Redwood City 12
Shenyang 12
Tianjin 12
Washington 12
Pune 11
Auburn Hills 10
Da Nang 10
Denver 10
Falls Church 10
Hangzhou 10
Nuremberg 10
Catania 9
Genoa 9
Miano 9
Nairobi 9
Palermo 9
Sydney 9
Toronto 9
Zhengzhou 9
Changsha 8
Grugliasco 8
Modena 8
Totale 9.088
Nome #
Continuità assistenziale ospedale-territorio per il paziente con scompenso cardiaco cronico: Una rivoluzione e una sfida nella cura ambulatoriale 1.166
Derivation and Validation of a Biomarker-Based Clinical Algorithm to Rule Out Sepsis From Noninfectious Systemic Inflammatory Response Syndrome at Emergency Department Admission: A Multicenter Prospective Study 403
Body composition and muscular strength changes after moderate activity: association with matrix metalloproteinase polymorphisms. 315
Carotid plaque vulnerability and matrix metalloproteinase -1 and -9 genetic polymorphisms 306
Oral anticoagulation and VKORC1 polymorphism in patients with a mechanical heart prosthesis: a 6-year follow-up 301
Coagulation indicators in patients with paroxysmal atrial fibrillation: Effects of electric and pharmacologic cardioversion. 300
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 285
D-dimer and anticoagulation in patients with mechanical prosthetic heart valves. A 2-year follow-up. 284
Features of vulnerable plaques and clinical outcome of UA/NSTEMI: Relationship with matrix metalloproteinase finctional polymorphisms. 278
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 272
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. 261
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 257
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 257
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients 252
Remodeling in acute coronary syndromes: expectations and frustrations for risk assessment and therapy. 245
Dissecting the expression of EEF1A1/A2 genes in human prostate cancer cells: the potential od EEF1A2 as a hallmark for prostate transformation and progression 243
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 240
MMP-9 microsatellite polymorphism: association with the progression of intima-media thickening and constrictive remodeling of carotid atherosclerotic plaques. 233
Disseminated tuberculosis in an immunocompetent patient 224
Insights into human hypertension: the role of endothelial dysfunction. 222
Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction. 220
Mechanisms of malnutrition in uremia. 219
Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome. 209
MMP-9 microsatellite polymorphism and multiple sclerosis. 201
Control of anticoagulant therapy with portable prothrombin time device in patients with mechanical heart valve prostheses: two-year follow-up 201
Platelet function and clotting parameters of vibration-exposed foundry workers. 200
Calciphylaxis of the breast: a rare disease in the differential diagnosis of breast cancer 199
Cyclin E1, E2 and E2F1 targeted siRNAs down regulate the growth of coronary smooth muscle cell, thus showing their potential use in the prevention of in-stent restenosis 199
Regulation of energy balance and blood pressure: are genetic polymorphisms pertinent? 196
MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration. 194
In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers. 190
MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis. 188
Improving siRNA Bio-Distribution and Minimizing Side Effects 188
Genetic approaches to hypertension: relevance to human hypertension 185
Inborn prothrombotic states 183
[Ximelagatran: a promising new drug for oral anticoagulation] 182
The Integration of qSOFA with Clinical Variables and Serum Biomarkers Improves the Prognostic Value of qSOFA Alone in Patients with Suspected or Confirmed Sepsis at ED Admission 182
Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors 181
Monitoring of hemostasis 178
Treatment of intermittent claudication with antiplatelet agents. 176
Proliferation of human primary vascular smooth muscle cells depends on serum response factor. 172
Heterogeneous models for an early discrimination between sepsis and non-infective SIRS in medical ward patients: a pilot study 171
[Disease management system in patients with chronic heart failure] 166
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. 162
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. 158
Long term prognosis in patients with peripheral arterial disease treated with antiplatelet agents. 157
Relation of haemostatic function, neurovascular impairment, and vibration exposure in workers with different stages of vibration induced white finger 157
MMP-2 genetic variant and plaque features of instability 154
Role of E2F1–Cyclin E1-Cyclin E2 Circuit in Human Coronary Smooth Muscle Cell Proliferation and Therapeutic Potential of Its Downregulation by siRNAs 153
Evaluation of principal risk factors, hemorheological and blood coagulation characteristics in arteriosclerosis obliterans in the elderly 152
null 150
Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease. 148
null 148
Psoriasis and endothelins. 147
null 146
Risk factors associated with early central nervous system damage detected through Diffusion Tensor Imaging (DTI) in patients with Systemic Lupus Erythematosus 142
Effects of various promoter derived sequences on the cleavage kinetic of an hammerhead ribozyme directed against cyclin E1 mRNA. 140
Genetic Variants of Matrix Metalloproteinase and Sepsis: The Need Speed Study 139
Evaluation of bortezomib impact on cell-cycle related genes in the hepatocellular carcinoma cell lines hepg2 and jhh6 by means of microarray analysis 133
null 121
Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose 121
Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases 112
New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins 103
null 96
Short term effects of doxycycline on matrix metalloproteinases 2 and 9. 95
Prostate Tumour-Inducing gene-1 analysis in human prostate cancer cells and tissue in relation to Mycoplasma infection 77
null 73
[Clinical practice: Ebstein's anomaly] 1
Totale 13.909
Categoria #
all - tutte 37.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.860


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022822 0 0 43 129 31 94 28 45 109 102 75 166
2022/20231.350 120 134 114 192 148 220 44 108 160 19 61 30
2023/2024798 61 65 44 56 97 73 84 119 19 42 71 67
2024/20251.496 34 47 85 132 188 148 107 94 203 177 119 162
2025/20263.284 332 191 226 310 267 324 460 77 351 472 109 165
2026/2027373 67 199 107 0 0 0 0 0 0 0 0 0
Totale 13.909